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Abstract 
The risk of bacterial infection of the endometrium causing uterine disease in cattle is increased in 
the progesterone-dominated luteal phase of the ovarian cycle, whilst oestrogens or oestrous are 
therapeutic or protect against disease. The first line of defence against bacteria such as Escherichia 
coli that cause inflammation of the endometrium is the innate immune system, which recognises 
bacterial lipopolysaccharide (LPS). The present study tested the hypothesis that cyclic variation in 
ovarian hormone concentrations alters innate immune responses within the bovine endometrium. 
Ex vivo organ cultures of endometrium, and in vitro cultures of endometrial epithelial and stromal 
cells, and peripheral blood mononuclear cells, all mounted inflammatory responses to E. coli or LPS, 
with secretion of inflammatory mediators IL-1β, IL-6 and IL-8, and increased expression of mRNA 
encoding IL1B, IL6, IL8 and CCL5. However, these inflammatory responses, typical of innate 
immunity, were not affected by the stage of ovarian cycle in which the endometrium was collected 
for organ culture, or by exogenous oestradiol or progesterone. Although a dexamethasone positive 
control reduced inflammation stimulated by E. coli or LPS, treatment with oestradiol or 
progesterone, or inhibitors of oestradiol or progesterone nuclear receptors, did not affect 
endometrial cell or peripheral blood mononuclear cell secretion of IL-1β, IL-6 or IL-8, or IL1B, IL6, IL8 
and CCL5 gene expression. In conclusion, the stage of oestrous cycle or ovarian steroids did not 
modulate the innate immune response in the bovine endometrium in vitro. 
 
Introduction 
Microbial infections of the uterus are a common cause of infertility, abortion, pre-term labour and 
clinical disease of humans and animals (Turner, et al. 2012, Wira, et al. 2005). In dairy cows, 
postpartum infection rates reach > 90% after parturition, with clinical disease evident in nearly half 
of these cows. Disease of the uterus may persist for several weeks, is refractory to current 
treatments, and leads to infertility (Sheldon, et al. 2009).  As a result, uterine disease of dairy cows is 
of economic importance, costing the EU dairy industry €1.4 billion per year (Sheldon, et al. 2009). 
Escherichia coli are an important cause of pathology in the endometrium (Sheldon, et al. 2010); with 
infection often preceding infection with Trueperella pyogenes and anaerobic bacteria (Sheldon, et al. 
2002). Furthermore, infection with E. coli is associated with negative effects on the ovary, 
hypothalamic-pituitary axis, and animal health and welfare (Williams, et al. 2007). The endometrium 
forms an essential barrier to infection of the uterus. Cytokines and chemokines orchestrate the 
recruitment and activation of immune cells to combat invading pathogens (Wira, et al. 2005). 
Responses to microbial infection depend on pattern recognition receptors, such as the Toll-like 
receptors (TLRs), which are expressed by the cells of the endometrium (Herath, et al. 2006, Herath, 
et al. 2009a, Sheldon and Bromfield 2011). In particular, endometrial epithelial and stromal cell 
responses to E. coli infection are mediated by TLR4, which binds lipopolysaccharide (LPS) leading to 
secretion of the chemokine IL-8 and the cytokine IL-6 (Cronin, et al. 2012).  
 
The endometrium undergoes physiological changes under the control of the ovarian steroids 
oestradiol and progesterone to create an environment suitable for pregnancy (Lewis 2003, Wira, et 
al. 2005). These steroids also have an impact on endometrial disease. During the follicular phase of 
the oestrous cycle, when oestradiol concentrations are high, the endometrium is more resistant to 
infection, whilst the progesterone-dominated luteal phase of the oestrous cycle is associated with a 
predisposition to development of disease (Lewis 2003, 2004, Rowson, et al. 1953). Despite the clear 
effect of ovarian cycle on uterine disease progression, mechanistic data for the immune polarising 
effects of oestradiol and progesterone are less apparent. However, differences in uterine cellular 
profiles have been noted. Cells harvested from the uterine lumen around the time of ovulation 
secrete higher concentrations of cytokines and chemokines compared with cells harvested during 
the luteal phase of the oestrous cycle (Fischer, et al. 2010). In some studies, ovarian steroids were 
associated with changes in neutrophil function (Roth, et al. 1983); whereas in other studies, there 
were no consistent differences in peripheral leukocyte populations or their function (Subandrio and 
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Noakes 1997, Subandrio, et al. 2000, Winters, et al. 2003). The inconsistency of leukocyte population 
differences and neutrophil functional changes, suggest that steroid control of uterine disease 
progression may be the product of altered endometrial cell responses. Exogenous oestradiol and 
progesterone alter prostaglandin secretion in vivo in cows, sheep and pigs (Del Vecchio, et al. 1992, 
Seals, et al. 2002, Wulster-Radcliffe, et al. 2003). In vitro, exogenous ovarian steroids reduce the 
secretion of prostaglandins by bovine epithelial and stromal cells stimulated with LPS (Herath, et al. 
2006). Therefore, we aimed to test whether stage of oestrous cycle or exogenous ovarian steroids 
might impact the innate immune response in the bovine endometrium using ex vivo studies to avoid 
confounding effects of humoral factors and adaptive immunity in vivo. 
 
The present study tested the hypothesis that cyclical variation in ovarian hormone concentrations 
alter cytokine and chemokine responses in bovine endometrial ex vivo organ cultures (EVOCs) and 
purified cell populations challenged with LPS or E. coli. Two main approaches were used. Firstly, 
inflammatory responses to E. coli or LPS were examined in tissues collected from animals at different 
stages of the oestrous cycle. Secondly, tissues and cells were treated with exogenous oestradiol and 
progesterone, or treated with inhibitors of the oestradiol or progesterone receptors. Comparisons 
were made to the glucocorticoid dexamethasone, which is an established modulator of innate 
immune responses (Kern, et al. 1988, Waage and Bakke 1988)  
 
Materials and methods 
Organ and cell culture 
Uteri with no gross evidence of genital disease or microbial infection were collected over a ten-
month period from postpubertal mixed-breed beef heifers or dairy cows within 15 min of slaughter 
at a commercial slaughterhouse, as part of the routine operation of the slaughterhouse. Cattle up to 
120 days post partum were not used to avoid confounding experiments due to the presence of 
ubiquitous bacterial contamination and disruption of the epithelium, which is typical of the 
puerperal endometrium (Herath, et al. 2009b, Wathes, et al. 2009). The beef heifers (n = 174) were 
twenty to twenty six months old, reared on extensive grassland and had never been pregnant or 
inseminated. Dairy cows that were pregnant, as determined when the uterine horns were opened 
(see below), were excluded from the study. The stage of reproductive cycle was determined by 
examination of ovarian morphology and vasculature, as described previously in detail (Ireland, et al. 
1979); and by the measurement of hormones in peripheral blood. In accordance with these criteria, 
stage I is defined as days 1–4 of the oestrous cycle; stage II, days 5–10; stage III, days 11–17, and 
stage IV as days 18–20. Only animals that had gross evidence of ovarian cyclic activity were included. 
To further evaluate the stage of ovarian cycle, blood samples were collected from the animal carcass 
at the time of uteri collection, allowed to clot at room temperature, and then centrifuged at 2000 x g 
for 15 min to separate the serum, which was then aliquoted into 1.5 ml eppendorf tubes and frozen 
at -80°C until used for progesterone analysis (see below). Within the present study animals from 
stages IV and I of the oestrous cycle were grouped together, since this represents the follicular phase 
when serum progesterone concentration is < 1 ng/ml. 
 
The uteri were kept on ice for approximately 1 h until further processing at the laboratory. 
Endometrial tissue for ex vivo organ culture (EVOC) was collected from the contralateral horn, unless 
otherwise stated, and the intercaruncular areas of the endometrium, except for comparison of 
responses between intercaruncular and caruncular tissue, using sterile 8 mm-diameter biopsy 
punches (Stiefel Laboratories Ltd, High Wycome, UK), as previously described (Borges, et al. 2012). 
Tissues were cultured in 24-well plates (TPP, Trasadingen, Switzerland) containing 2 ml complete 
medium per well, comprised of: Phenol red-free Roswell Park Memorial Institute (RPMI) 1640 
medium (Sigma-Aldrich) containing 10% heat inactivated, double charcoal-stripped, fetal bovine 
serum (FBS; Biosera, East Sussex, UK). The EVOC treatments (see below) were initiated within 4 h of 
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slaughter, and maintained in a humidified, 5% CO2 in air atmosphere incubator at 37°C, with 
supernatants collected 6 h, 24 h or 48 h later.  
 
Endometrial cells were isolated as described previously (Cronin, et al. 2012, Turner, et al. 2014). The 
epithelial and stromal cells were cultured in complete medium and plated at 1 × 105 cells/ml in 24-
well plates (TPP). The purity of epithelial and stromal cell populations was confirmed by cell 
morphology and flow cytomteric analysis of cytokeratin and vimentin expression, respectively 
(Fortier, et al. 1988, Turner, et al. 2014). 
 
The isolation and culture of peripheral blood mononuclear cells (PBMCs) was performed as 
described (Amos, et al. 2014, Herath, et al. 2007).Cells were seeded into 24-well plates at 1 x 106 
cells/well in 1 ml of complete medium and medium changed every two days for until cells exhibited 
characteristic macrophage morphology (Steinman and Cohn 1973). The cell population phenotype, 
which was CD14+, CD45+ and MHC class II+, was confirmed by flow cytometry as previously 
described (Herath, et al. 2007, Price, et al. 2013). 
 
Experimental design 
Treatments 
Cultures of E. coli (isolate MS499) obtained from an animal with persistent uterine disease, and 
identified as an endometrial pathogenic E. coli (Goldstone, et al. 2014, Sheldon, et al. 2010), were 
grown overnight in Luria-Bretani medium (Sigma-Aldrich). Bacteria were re-suspended to 1 x 108 
colony forming units (CFU)/ml in sterile PBS (Life Technologies Ltd, Paisley, UK), followed by 
centrifugation at 6000 x g for 10 min at 4°C. After washing, bacteria were diluted to 1 x 103 CFU/ml 
in complete medium ready for experimental use. Ultrapure LPS from E. coli 0111:B4 was obtained 
from Invivogen (Toulouse, France). Ovarian and glucocorticoid steroids (Oestradiol, E2758; 
progesterone, P8783; dexamethasone, D4902) and the steroid receptor antagonists (MPP 
dihydrochloride hydrate, M7068; mifepristone, M8046) were obtained from Sigma-Aldrich Ltd. 
Ovarian and glucocorticoid steroids were prepared by dissolving 1 mg of the steroid in 1 ml absolute 
ethanol. Stock solutions were prepared at 20 μg/ml in complete medium. Final concentrations of 
oestradiol, progesterone and dexamethasone were prepared by further dilutions in complete 
medium. The final concentration of ethanol within tissue or cell cultures was equal to or less than 1 
part in 200,000. MPP dihydrochloride hydrate was prepared by dissolving 20 mg in 1 ml dimethyl 
sulfoxide. A stock solution was prepared at 1 mg/ml (1.85 mM) in complete medium. The final 
concentration of MPP dihydrochloride hydrate (100 nM) was prepared by further dilution in 
complete medium. The final concentration of dimethyl sulfoxide within tissue of cell cultures was 1 
part in 370,000. Mifepristone was prepared by dissolving 10 mg in 1 ml absolute ethanol. A stock 
solution was prepared at 1 mg/ml (2.32 mM) in complete medium. The final concentration of 
mifepristone (100 nM) was prepared by further dilution in complete medium. The final 
concentration of ethanol within tissue of cell cultures was 1 part in 232,000. All treatments were 
performed in complete medium that did not contain antibiotics to ensure bacteria were alive and 
replicating. 
 
Validation of innate immune responses of endometrial ex vivo organ cultures 
To compare endometrial innate immune responses between beef heifers and dairy cows, EVOCs 
were prepared from beef heifer (n = 9) and dairy (n = 7) cow uteri that were within the early-luteal 
phase of the oestrous cycle. Comparison of EVOCs using endometrial tissue from intercaruncular (n = 
4) and caruncular (n = 4) zones of the endometrium was performed using early luteal phase beef 
heifer uteri. Endometrial EVOCs were treated with control medium or medium containing 1 µg/ml 
LPS or 1 x 103 CFU/ml E. coli for 24 h. Comparison of EVOCs using endometrial tissue from the horn 
ipsilateral (n = 13) and contralateral (n = 29) to the active CL structure was performed using early 
luteal phase beef heifer uteri. Endometrial EVOCs were treated with control medium or medium 
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containing 1 µg/ml LPS for 24 h. After treatment, supernatants were collected and stored at -20°C 
for analysis of IL-1β, IL-6 and IL-8 by ELISA. The EVOC tissues were weighed, and stored in 0.5 ml TRI 
Reagent® at -20°C until RNA extraction and analysis of IL1B, IL6 and IL8 mRNA expression by qPCR. 
 
Uterine innate immune responses and stage of oestrous cycle  
To evaluate the effect of the stage of oestrous cycle, tissues from 55 beef heifers were divided into 
three groups by examination of ovarian morphology (Ireland, et al. 1979) and retrospective serum 
progesterone analysis (see below): Follicular phase was defined by ovarian stage (Ireland et al 1979 - 
stage IV and I) with serum progesterone concentration < 1 ng/ml (n = 6); early-luteal phase (Ireland 
et al 1979 - stage II) with serum progesterone concentration 1 to 2 ng/ml (n = 10); and mid-luteal 
phase (Ireland et al 1979 - stage III) with serum progesterone concentration > 2 ng/ml (n = 39). 
Endometrial EVOCs from each group were treated with control medium or medium containing 1 
µg/ml LPS or 1 x 103 CFU/ml E. coli for 6 h or 24 h. After treatment, supernatants were collected and 
stored at -20°C for analysis of IL-1β, IL-6, IL-8 and PGE2 by ELISA. The EVOC tissues were weighed, 
and stored in 0.5 ml TRI Reagent® at -20°C until RNA extraction and analysis of IL1B, IL6, IL8 and CCL5 
mRNA expression by qPCR. 
 
Steroids and innate immune responses within ex vivo organ cultures 
Seventy six beef heifers were used to evaluate the effect of ovarian and glucocorticoid steroids on 
innate immune responses within the bovine endometrium. Endometrial EVOCs were divided into 
two groups according to retrospective analysis of serum progesterone concentration: group 1 with 
serum progesterone concentration < 2ng/ml (n = 20); group 2 with serum progesterone 
concentration > 2 ng/ml (n = 56). Endometrial EVOCs were pre-treated for 24 h with control medium 
or medium containing 3 pg/ml oestradiol, 5 ng/ml progesterone or 5 ng/ml dexamethasone. The 
concentration of oestradiol and progesterone reflect serum concentrations around the time of 
ovulation and during the luteal phase of the oestrous cycle, respectively (Jimenez-Krassel, et al. 
2009, Scully, et al. 2014, Sheldon, et al. 2002). The concentration of dexamethasone used was based 
upon the recommended potency range from the manufacturer (4 to 500 ng/ml) and a previous 
publication, with the aim being to use a minimal effective dose (Kern, et al. 1988). After 24 h, EVOCs 
were challenged with control medium or medium containing 1 µg/ml LPS or 1 x 103 CFU/ml E. coli for 
a further 24 h in the presence of the steroids. After challenge, supernatants were collected and 
stored at -20°C for analysis of IL-1β, IL-6 and IL-8 by ELISA. The EVOC tissues were weighed, and 
stored in 0.5 ml TRI Reagent® at -20°C for analysis of IL1B, IL6, IL8 and CCL5. In addition, the 
expression of ESR1 and PGR mRNA was determined by qPCR to ensure the tissue remained 
responsive to exogenous steroids for the 48 h treatment period. 
  
Steroids and cellular innate immune responses 
To evaluate the impact of ovarian and glucocorticoid steroids on in vitro cellular innate immune 
responses, endometrial epithelial and stromal cells, and PBMCs, collected from four beef heifers 
were pre-treated for 24 h with control medium or medium containing 3 pg/ml oestradiol, 5 ng/ml 
progesterone or 5 ng/ml dexamethasone. After 24 h, cells were challenged with control medium or 
medium containing 100 ng/ml LPS for a further 24 h in the presence of the steroids. After challenge, 
supernatants were collected and stored at -20°C for analysis of IL-6 and IL-8 by ELISA. Additionally, 
endometrial stromal cells from three beef heifers were pre-treated for 24 h with control medium or 
medium containing 1 to 30 pg/ml oestradiol, 1 to 30 ng/ml progesterone or 5 ng/ml dexamethasone. 
After 24 h, cells were challenged with control medium or medium containing 100 ng/ml LPS for a 
further 24 h in the presence of the steroids. After challenge, supernatants were collected and stored 
at -20°C for analysis of IL-6 and IL-8 by ELISA. Cell survival was assessed by the mitochondria-
dependent reduction of 3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to 
formazan, as previously described (Mosmann 1983). Briefly, supernatants were removed and 
replaced with fresh complete medium containing 0.5 mg/ml MTT before being incubated with the 
6 
 
cells at 37°C in a humidified, 5% CO2 in air incubator for 1 h. The medium was then removed and the 
cells washed with sterile PBS prior to lysis with dimethyl sulfoxide and measurement of the optical 
density at 570 nm using a microplate reader (POLARstar Omega; BMG Labtech, Offenburg, 
Germany). The correlation between MTT OD 570 measurements and the number of live cells was 
confirmed using trypan blue exclusion and counting the number of live cells using a 
haemocytometer. 
 
Steroid receptor antagonists and endometrial innate immune responses 
To further explore the impact of steroids on immunity in the endometrium, their actions were 
inhibited using antagonists for their nuclear receptors. Endometrial EVOCs from 23 beef heifers in 
the luteal phase of the oestrous cycle were pre-treated for 24 h with control medium or medium 
containing 5 ng/ml progesterone, 3 pg/ml oestradiol or 5 ng/ml dexamethasone. Pre-treatments 
were performed in the presence or absence of the oestrogen receptor alpha (ERα) antagonist MPP 
dihydrochloride hydrate (MPP, 100 nM) (Sun, et al. 2002) or the progesterone/glucocorticoid 
receptor (PR/GR) antagonist mifepristone (100 nM) (Siemieniuch, et al. 2010, Skinner, et al. 1999). 
After 24 h, the EVOCs were challenged with control medium or medium containing 1 µg/ml LPS or 1 
x 103 CFU/ml E. coli for a further 24 h in the presence of the steroids and/or antagonists. After 
challenge, supernatants were collected and stored at -20°C for analysis of IL-1β, IL-6 and IL-8 by 
ELISA, and EVOC tissues were weighed. 
 
Enzyme immune assays 
Concentrations of IL-1β, IL-6 and IL-8 in EVOC and cell culture supernatants were measured in 
duplicate by ELISA according to the manufacturer’s instructions [Bovine IL-1β Screening Set 
(ESS0027; ThermoFisher Scientific, Perbio Science UK Ltd, Cramlington, UK); Bovine IL-6 Screening 
Set (ESS0029; ThermoFisher Scientific); Human CXCL8/IL-8 DuoSet (DY208; R&D Systems Europe Ltd., 
Abingdon, UK)]. The human CXCL8/IL-8 DuoSet has previously been validated for the measurement 
of bovine IL-8 (Rinaldi, et al. 2008). To take into account differences between the weights of EVOC 
tissues, concentrations are reported as picogram per milligram of tissue. Serum progesterone 
concentrations were determined using a Progesterone Enzyme Immunoassay (Ridgeway Research 
Ltd, St Briavels, UK), according to the manufacturer’s instructions. The inter-assay and intra-assay 
coefficients of variation were all less than 12% and 7%, respectively; the limits of detection were 
12.5 pg/mL for IL-1β, 75.0 pg/mL for IL-6, 5.7 pg/mL for IL-8, and 0.1 ng/mL for progesterone. 
 
Gene expression analysis 
Gene expression analysis was performed according to MIQE guidelines (Bustin, et al. 2009). Total 
RNA was isolated from EVOC tissues by homogenising the tissue in 2 ml tubes containing 0.5 ml TRI 
Reagent® (Sigma-Aldrich) and lysing matrix D (MP Biomedicals, Cambridge, UK) at 6.0 m/sec for 2 
min. After homogenization, tubes were centrifuged at 12,000 × g for 10 min, the supernatants 
transferred to fresh 2 ml eppendorf tubes, and RNA extraction from TRI Reagent® then performed 
according to the manufacturer’s instructions. Reverse transcription of 1 µg mRNA was performed in 
a 20 µl reaction using the QuantiTect Reverse Transcription kit (Qiagen, Manchester, UK) according 
to the manufacturer’s instructions. 
 
Quantitative PCR (qPCR) for IL1B, IL8, CCL5, ESR1, GAPDH and ACTB was performed by multiplex 
probe-based PCR, and comprised two panels of primer/probe combinations (panel 1 = IL1B, IL8, and 
GAPDH; panel 2 = CCL5, ESR1 and ACTB), which simultaneously measured cDNA for each target gene. 
PCR primers and probes were designed using Eurofins MWG Operon qPCR primer/probe design 
software (https://ecom.mwgdna.com/services/webgist/dual_probe_design?usca_p=t) and validated 
by BLAST analysis against the Bos taurus (taxid:9913) Refseq mRNA database. Primers/probes were 
obtained from Eurofins MWG Operon, Ebersberg, Germany. Multiplex qPCR was performed in 10 µl 
reactions comprising 1 × QuantiFast Multiplex PCR master mix (Qiagen) with primers and probes 
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added in nuclease-free water to a final concentration of 0.4 µM and 0.2 µM respectively and 2 µl of 
cDNA. Thermal cycling parameters were: 1 cycle of 95°C for 5 min followed by 50 cycles of 95°C for 
15 sec and 60°C for 30 sec.  
 
Quantitative PCR for IL-6 and PGR was performed by SYBR green based PCR because existing 
primers/methods for these genes were already present in the lab. PCR primers were designed using 
Eurofins MWG Operon qPCR primer/probe design software 
(https://ecom.mwgdna.com/services/webgist/dual_probe_design?usca_p=t) and validated by BLAST 
analysis against the Bos taurus (taxid:9913) Refseq mRNA database. PGR and IL6 primers were 
obtained from Eurofins MWG Operon and Sigma-Aldrich, respectively. SYBR-based PCR was 
performed in a 25 µl reaction comprising 1 x QuantiFast SYBR green PCR master mix (Qiagen) with 
primers added in nuclease-free water to a final concentration of 0.4 µM and 2 µl of cDNA. Thermal 
cycling parameters were: 1 cycle of 95°C for 5 min, followed by 40 cycles of 95°C for 30 sec and 60°C 
for 60 sec.  
 
All primers and probes used are detailed in Table 1. The expression of each gene was normalised 
against the geometric mean of the reference genes GAPDH and ACTB, which were invariant across 
treatment groups (Vandesompele, et al. 2002), and the relative quantification method employed to 
quantify target gene mRNA within samples (Nolan, et al. 2006). To generate standard curves, total 
RNA extracted from EVOC tissues that had been treated with 1 µg/ml LPS for 24 h, was reverse 
transcribed to cDNA, as described. Ten-fold serial dilutions of this reference cDNA were prepared 
(neat to 1 x 10-5) in nuclease-free water (Qiagen). For each sample, target and reference gene mRNA 
abundance was determined from the appropriate standard curve (quantification cycle, Cq). Changes 
in mRNA abundance between samples were then determined from the ratio of the target gene Cq to 
reference gene Cq.  
 
Data analysis 
Statistical analyses were performed using SAS version 8.0 with the animal as the experimental unit. 
Initially the data were tested for homogeneity, followed by analysis using General Linear Model 
multiplex analysis of variance (GLM-ANOVA) using Dunett’s pair-wise multiple comparison t-test for 
individual group comparisons. Gene data are presented as dot plots, protein data are presented as 
histograms, data are presented as mean with standard error (SEM) and P < 0.05 was considered 
statistically significant. 
 
Results 
Endometrial EVOCs from beef heifers and dairy cows respond similarly to LPS and E. coli 
To validate the utility of the EVOC system, selected cytokine and chemokine responses were 
compared between EVOCs from beef heifer and dairy cow endometrium. Endometrial EVOCs from 
beef heifers and dairy cows accumulated more IL-1β, IL-6 and IL-8 following challenge with LPS or E. 
coli compared with control medium (Fig. 1A-C: P < 0.0001). There was also increased IL1B, IL6 and 
IL8 mRNA expression in response to challenge with LPS or E. coli (Fig. 1D-F: P < 0.0001). However, 
there was no significant difference in the protein or mRNA responses to LPS or E. coli between 
EVOCs from beef heifers and dairy cows.  
 
To further validate the use of EVOCs, inflammatory responses to E. coli and LPS were compared 
between caruncular and intercaruncular EVOCs collected from beef heifer endometrium. 
Endometrial EVOCs from both areas secreted more IL-1β, IL-6 and IL-8 in response to challenge with 
LPS or E. coli compared with control medium (Fig. 1G-I: P < 0.05). However, more IL-1β, IL-6 and IL-8 
was secreted from intercaruncular EVOCs compared with caruncular EVOCs following challenge with 
LPS (P < 0.05), and more IL-1β and IL-6 was secreted following challenge with E. coli (P < 0.05).  
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Finally, inflammatory responses to LPS were compared between endometrial EVOCs collected from 
the horn ipsilateral and contralateral to the active CL structure. Endometrial EVOCs from both horns 
secreted more IL-6 in response to challenge with LPS compared with control medium (Fig. 1K: P < 
0.001), and there was a trend for increased IL-1β and IL-8. Importantly, however, there were no 
significant differences in responses to LPS between EVOCs from the ipsilateral or contralateral horns. 
 
Endometrial innate immune responses and stage of oestrous cycle 
To investigate the role of the oestrous cycle in modulating innate immunity, responses to challenge 
with LPS or E. coli for 6 h or 24 h were tested using EVOCs of intercaruncular endometrium collected 
from beef animals at different stages of the oestrous cycle. As expected, cows in the mid-luteal 
phase had more progesterone present in their serum (8.51 + 0.75 ng/ml: P < 0.001) compared with 
cows in the follicular (0.08 + 0.07 ng/ml) or early luteal (0.5 + 0.21 ng/ml) phases.  
 
Following a 6 h challenge with LPS or E. coli, EVOCs accumulated more IL-6 (P < 0.0001), compared 
with control medium, and after a 24 h challenge with LPS or E. coli, more IL-1β, IL-6 and IL-8 (P < 
0.0001) (Fig. 2). Mid-luteal phase cow EVOCs accumulated more IL-6 (P < 0.05), but not IL-1β or IL-8, 
in response to a 6 h challenge with LPS compared with follicular and early luteal phase cow EVOCs 
(Fig. 2A-C). There were no significant differences between stages of oestrous cycle following a 6 h 
challenge with E. coli. Mid-luteal phase cow EVOCs accumulated less IL-1β (P < 0.05) compared with 
early-luteal phase cow EVOCs following a 24 h challenge with E. coli, but there was no difference in 
IL-6 or IL-8 secretion (Fig. 2D-F). There were no significant differences between stages of oestrous 
cycle for EVOCs challenged with LPS for 24 h. To further explore the impact of stage of the oestrous 
cycle on inflammatory responses in the endometrium, the EVOC data were combined (Follicular, n = 
19; Early-luteal, n = 43; Mid-luteal, n = 22). Treatment with LPS or E. coli increased the accumulation 
of IL-6 compared with control (305.7 ± 13.1, 243.4 ± 12.4, 93.1 ± 13.9 pg/ml, respectively; ANOVA, P 
< 0.001). However, there was no significant effect of stage of cycle (P = 0.23) or the interaction 
between treatment and stage (P = 0.88). 
 
Challenge of EVOCs with E. coli or LPS for 6 h or 24 h also increased the expression of IL1B, IL6, IL8 
and CCL5 (Fig. 3: P < 0.05). However, there were no consistent differences in mRNA expression 
amongst the different stages of oestrous cycle measured for any of the four genes examined at 6 h 
or 24 h (Fig. 3).   
 
Ovarian steroids and endometrial responses to LPS or E. coli 
In the absence of an effect of the stage of oestrous cycle on the inflammatory response, an 
alternative approach was examined to test if ovarian steroids regulate endometrial innate immunity, 
by treating EVOCs with exogenous steroids prior to challenge with LPS or E. coli. The EVOCs were 
retrospectively divided into two groups, based on serum progesterone concentration: < 2 ng/ml 
(follicular) and > 2 ng/ml (luteal). As ovarian hormones regulate the ESR1 and PGR genes (Kimmins 
and MacLaren 2001), to confirm the responsiveness of the EVOC to steroid treatment, the impact of 
oestradiol, progesterone and the glucocorticoid dexamethasone on ESR1 and PGR mRNA expression 
was measured. Within EVOCs of follicular phase endometrial tissue, 48 h treatment with oestradiol 
increased the expression of ESR1 (Fig. 4A: P < 0.05) and PGR (Fig. 4C: P < 0.05) mRNA compared with 
the control, and progesterone significantly decreased the expression of PGR (Fig. 4C: P < 0.05) 
mRNA, whilst dexamethasone had no effect (Fig. 4A, C). The same pattern of change in expression of 
PGR mRNA was measured in EVOCs from luteal phase cows (Fig. 4D: P < 0.05), but none of the 
steroids had any significant effect on ESR1.  
 
As previously, irrespective of steroid treatment EVOCs responded to challenge with LPS by 
accumulating IL-6 and IL-8; and, accumulated IL-6, IL-8 and IL-1β in response to challenge with E. coli 
(Fig. 5: P < 0.05). However, pre-treatment of EVOCs with either oestradiol or progesterone for 24 h 
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had no significant effect on responses to subsequent challenge with LPS or E. coli, and there was no 
effect of the prior hormone concentration in the animals. Although, dexamethasone reduced the 
accumulation of IL-1β in EVOCs prior to, and following challenge with LPS or E. coli (Fig. 5A, B: P < 
0.05). As previously, challenge of EVOCs with LPS or E. coli increased the expression of IL1B, IL6, IL8 
and CCL5 mRNA compared with control medium (Fig. 6: P < 0.001). However, pre-treatment with 
oestradiol or progesterone had no effect on mRNA abundance in response to these challenges, and 
again this was irrespective of the prior hormone concentration in the animals. In contrast, pre-
treatment with dexamethasone reduced the expression of IL1B (Fig. 6A, B: P < 0.05) and IL8 (Fig. 6 E, 
F: P < 0.05) in EVOCs prior to, and following challenge with LPS or E. coli, and CCL5 (Fig. 6 G, H: P < 
0.05) following challenge with LPS or E. coli, compared with control medium.  
 
To determine whether the lack of effect of ovarian steroids on endometrial innate immune 
responses was unique to the EVOCs, experiments were also conducted using pure populations of 
endometrial cells. Endometrial epithelial cells, stromal cells and PBMCs accumulated IL-6 (Fig. 7A-C) 
and IL-8 (Fig. 7 D-F) in response to challenge with LPS for 24 h (P < 0.001). However, pre-treatment 
with oestradiol or progesterone for 24 h had no significant effect on IL-6 or IL-8 production of each 
of the three cell types. Although, pre-treatment with dexamethasone reduced the accumulation of 
IL-6 in epithelial cells (Fig. 7A: P < 0.05), and IL-8 in stromal cells and PBMCs (Fig. 7E, F: P < 0.05). 
 
However, different concentrations of exogenous steroid could modulate cellular responses, so 
endometrial stromal cells were treated with a range of concentrations of oestradiol or progesterone, 
prior to challenge with LPS. Stromal cells were used for two reasons: firstly, stromal cells are more 
responsive to LPS than epithelial cells, and the increased dynamic range gave the best chance of 
observing and effect. Secondly, epithelial cells are lost during and after parturition exposing the 
underlying stromal cells to bacterial infection (Archbald, et al. 1972). Pre-treatment of endometrial 
stromal cells with 1 to 30 pg/ml oestradiol (Fig. 8A, C), or 1 to 30 ng/ml progesterone (Fig. 8B, D) for 
24 h, did not modulate IL-6 or IL-8 responses to LPS during subsequent challenge. 
 
Ovarian steroid receptor antagonists and endometrial responses to LPS or E. coli  
To examine whether steroid nuclear receptor function modulates endometrial innate immunity, 
EVOCs were pre-treated with the oestrogen receptor alpha antagonist MMP or the 
progesterone/glucocorticoid receptor antagonist mifepristone, with or without the appropriate 
steroid present. After the 24 h pre-treatment, EVOCs were challenged with control medium or 
medium containing LPS or E. coli. Endometrial EVOCs accumulated IL-1β, IL-6 and IL-8 in response to 
challenge with LPS and IL-1β and IL-6 following challenge with E. coli (Fig. 9: P < 0.0001). Pre-
treatment of EVOCs for 24 h with oestradiol and/or MPP had no effect on endometrial responses to 
challenge with LPS or E. coli (Fig. 9A, D, G). Pre-treatment for 24 h with progesterone and/or 
mifepristone also had no significant effect on endometrial responses to challenge with LPS or E. coli 
(Fig. 9B, E, H). However, pre-treatment with dexamethasone reduced (P < 0.05) the accumulation of 
IL-1β in response to challenge with E. coli, and importantly, pre-treatment with dexamethasone and 
mifepristone blocked the IL-1β inhibiting effect of dexamethasone (Fig. 9C: P < 0.05). 
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Discussion 
In vivo, there is clear evidence for a protective effect of oestradiol or oestrous against infection of 
the uterus, and of a disease-promoting effect for progesterone or the luteal phase of the oestrous 
cycle (Del Vecchio, et al. 1992, Lewis 2004, Rowson, et al. 1953). Although, several explanations for 
these effects have been explored previously, the mechanistic explanations are elusive, particularly in 
relation to leukocyte population differences and neutrophil function (Subandrio and Noakes 1997, 
Subandrio, et al. 2000, Winters, et al. 2003). Thus, we reasoned that ovarian steroids might 
modulate innate immune responses in the endometrium. However, in the present study the stage of 
oestrous cycle did not influence the cytokine or chemokine response of ex vivo endometrial tissue to 
E. coli or LPS at the gene or the protein level. Furthermore, exogenous ovarian steroids did not 
modulate the innate immune response by endometrial tissue or cells. Finally, even blocking the 
nuclear receptors for oestradiol or progesterone did not impact the inflammatory response to E. coli 
or LPS. We conclude that ovarian steroids have little effect on in vitro inflammatory responses 
associated with innate immunity in the bovine endometrium. 
 
The use of EVOCs maintains the architecture of the cells in the tissue, and retains an imprint of the 
stage of oestrous cycle of the animal. Using EVOCs also avoids potential confounders of in vivo 
studies, including humoral factors, effects of nutrition, and adaptive immune responses, enabling 
exploration of the impact of steroids in the localized tissue and cells of the endometrium, 
independent of the whole animal response. In the present study, endometrial EVOCs from beef 
heifers were a good surrogate for tissues from dairy cows, producing similar cytokine and chemokine 
responses to E. coli and LPS. Furthermore, using tissue and cells from beef heifers removed potential 
confounders in dairy cows, such as  insemination, pregnancy, previous uterine disease, and lactation. 
Yet the increased cytokine and chemokine secretion, and increased mRNA expression following 
challenge of EVOCs with E. coli or LPS mirror the changes during disease  in vivo (Herath, et al. 
2009b, Sheldon, et al. 2009). Additionally, EVOCs collected from the horn ipsilateral or contralateral 
to the active corpus luteum were equally responsive to LPS, suggesting that the inflammatory 
response is not modulated by differing concentration gradients of hormone across the two horns. 
This view is supported by gene array analyses, which report hundreds of differentially expressed 
genes in the endometrium of luteal versus follicular phase animals, but very few genes differ in 
expression between the horn ispsilateral and contralateral to the corpus luteum, and those that do 
have very low ratios (Bauersachs, et al. 2005, Shimizu, et al. 2010). However, EVOCs incorporating 
tissue from intercaruncular areas of the endometrium were more responsive to challenge with LPS 
or E. coli than caruncular tissue. With over 1100 differentially expressed genes between 
intercaruncular and caruncular tissue, including several inflammation and immune regulating genes 
(Mansouri-Attia, et al. 2009), use of tissues from the intercaruncular zones was an important 
optimization step.  
 
Central to the response to bacterial challenge is the detection of pathogen associated molecular 
patterns by TLRs, and in particular for E. coli infection, binding of LPS by TLR4. Endometrial epithelial 
and stromal cells also express TLRs, including TLR4, and produce IL-6 and IL-8 following challenge 
with LPS (Herath, et al. 2006, Sheldon and Roberts 2010). In the present study, E. coli and LPS 
stimulated the accumulation of IL-1β and IL-8 by 24 h. The kinetics of IL-6 production likely reflects 
the roles of IL-6 in the early response to infection such as leukocyte recruitment, B-lymphocyte 
development, antibody secretion by plasma cells , and the regulation of acute-phase proteins. 
Interleukin-8, a potent chemo-attractor and activator of neutrophils and T-lymphocytes, is secreted 
by monocytes, lymphocytes, fibroblasts, epithelial and endothelial cells (Mukaida 2000, Schaefer, et 
al. 2004). Interleukin-1β is secreted predominantly by monocytes following inflammasome activation 
and stimulates the production of additional pro-inflammatory cytokines, such as IL-6 (van de 
Veerdonk, et al. 2011), and chemokines such as IL-8, which recruit more immune cells, and promote 
phagocytosis and bacterial clearance (Petrilli, et al. 2007). 
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The most striking observations in the present study were that endometrial tissue and cell responses 
to challenge with E. coli or LPS were not influenced by the stage of oestrous cycle, or by the addition 
of exogenous oestradiol or progesterone. First we found that the stage of oestrous cycle did not 
affect innate immune responses of endometrial EVOCs challenged with LPS or E. coli. So, we 
considered whether separating out the cellular populations would uncover steroid-responsive 
effects, using differential regulation of ESR1 and PGR mRNA to verify that the endometrial cells were 
responsive to exogenous oestradiol and progesterone. However, ovarian steroids had no effect on 
separated endometrial cell or PBMC responses to challenge with LPS or E. coli, and similarly, 
inhibition of oestrogen receptor alpha or progesterone receptor had no effect on innate immune 
responses; although, inhibiting the glucocorticoid receptor inhibited dexamethasone related 
inflammatory modulation. One could argue that the initial staging of the oestrous cycle may have 
been erroneous. However, more than 150 animals were used across the studies, peripheral plasma 
progesterone concentrations were used to verify the stage of cycle, and the variance across groups 
was small irrespective of the stage of cycle. It could also be argued that higher steroid 
concentrations in the uterine tissue, compared to the peripheral plasma, might effectively modulate 
inflammatory responses (Einer-Jensen, et al. 1989, McCracken, et al. 1984, Weems, et al. 1988). 
However, extended dose range experiments showed no effect on inflammatory responses to LPS, 
and EVOC tissue had been exposed to native uterine steroid concentrations. Taken together, these 
data suggest that there is neither a direct effect of the ovarian steroids on innate immunity nor is 
oestrous cyclic regulation of ovarian steroid receptor expression likely to impact innate immunity. 
 
In vivo, there is a clear oestrous-dependant effect on basal mRNA expression of cytokines and 
chemokines such as IL1B, IL8 and CXCL5 in cells collected from the uterine lumen (Fischer, et al. 
2010). So, how do the present study’s negative results in vitro fit into the whole animal effects? 
Firstly, there may be an innate immune effect mediated by regulatory molecules not investigated in 
this study. In vitro, exogenous ovarian steroids reduce the synthesis of prostaglandin F2α and 
prostaglandin E2 in endometrial cells (Herath, et al. 2006). Other classes of molecules, such as 
antimicrobial peptides, lipoxins or resolvins could also be examined. Secondly, alteration of the 
adaptive immune response would have a significant effect on disease outcome. The presence of 
ovarian steroid receptors on immune cells suggests the possibility of their regulation, and there is 
evidence from humans that ovarian steroids have a significant impact on disease outcome 
(Rodriguez-Garcia, et al. 2013a, Rodriguez-Garcia, et al. 2013b, Waage, et al. 1990, Wira, et al. 2005). 
Thirdly, there may be an indirect effect of ovarian steroids on innate or adaptive immunity. Indeed, 
in the present study dexamethasone reduced IL-1β, IL-6 and IL-8 secretion, together with IL1B, IL6, 
IL8 and CCL5 mRNA responses to challenge with E. coli or LPS. In addition, the GR antagonist 
mifepristone attenuated the suppressive effect of dexamethasone on IL-1β secretion following E. 
coli challenge. Kuse et al recently demonstrated a regulatory effect of ovarian steroids on NR3C1 
expression within the bovine endometrium. As a function of stage of the oestrous cycle, NR3C1 
expression within the bovine endometrium was greater during the mid-luteal phase when 
progesterone concentrations are high, compared with other phases of the oestrous cycle, and the 
glucocorticoid cortisol more strongly suppressed PGF2α production during the mid-luteal phase than 
during the follicular phase. The addition of progesterone to cultured endometrial epithelial cells also 
increased expression of NR3C1, whilst oestradiol reduced expression levels (Kuse, et al. 2013). A 
future approach might also probe single cell responses to PAMPs and steroids since although the 
present study has shown no response to ovarian steroids within large populations of cells in vitro, 
individual cells may respond. Indeed, such an approach recently revealed the production of the 
lymphosteroid pregnenolone by Th2 T cells, which is associated with immunosuppression, inhibiting 
Th cell proliferation and B cell immunoglobulin class switching (Mahata, et al. 2014). 
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In conclusion, there was no effect of the stage of oestrous cycle, exogenous ovarian steroids, or 
inhibiting their nuclear receptors on key cytokine and chemokine responses to E. coli or LPS in 
endometrial tissues or cells. The lack of effect of ovarian steroids challenges the central dogma that 
steroids suppress immunity across species. 
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Table 1:  
Quantitative PCR primers and probes used for gene expression analysis. 
 
Gene Primers/probes (5’ – 3’) 
IL1B 
Forward: TCCTATTCTCTCCAGCCA 
Reverse: AGCCTCAAATAACAGCTCATTC 
Probe: FAM-ATGGCAACCGTACCTGAACCCATCAA-BHQ1 
IL8 
Forward: CACATTCCACACCTTTCCAC 
Reverse: CCTTCTGCACCCACTTTTC 
Probe: Hex-GGAAACGAGGTCTGCCTAAACCCCAA-BHQ1 
GAPDH 
Forward: ATTCCACCCACGGCAAGTTC 
Reverse: TCCATCGTCCACCGCAAATGCTTCT 
Probe: Cy5-GCAGAGAACGGGAAGCTCGTCATCAATGGAA-BBQ650 
CCL5 
Forward: CTTTGCCTATATCTCCCGCC 
Reverse: TCTCGCACCCACTTCTTCTC 
Probe: FAM-CAGCAGTTGTCTTTATCACCAGGAAGAAGCGCCA-BHQ1 
ACTB 
Forward: AAGAAAAAGGGTGTAACGCAG 
Reverse: TCCATCGTCCACCGCAAATGCTTCT 
Probe: LC705-ATTCCACCCACGGCAAGTTC-BBQ650 
ESR1 
Forward: ACTCCTCCTCATCCTCTCTC 
Reverse: CACCACGTTCTTGCACTTC 
Probe: Hex-GGCACATGAGCAACAAAGGCATGGA-BHQ1 
IL6 Forward: ATGACTTCTGCTTTCCCTACCC Reverse: GCTGCTTTCACACTCATCATTC 
PGR Forward: CGTGGAGGGGGCGTATTCCG Reverse: CGGGGCCAAAGAGGCACCAA 
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Figure legends 
Figure 1 
Ex vivo organ culture responses to LPS or E. coli. Endometrial EVOCs were collected from the 
intercarulcular areas (contralateral horn) of early luteal beef heifer  (Open bars or ) and dairy cow 
(Closed bars or ) endometrium,  and challenged with control medium or medium containing 1 
µg/ml LPS or 1 x 103 CFU/ml E. coli for 24 h. Supernatants were collected and analysed for IL-1β, IL-6 
and IL-8 by ELISA (A – C: Beef heifers, n = 9; dairy cows, n = 7) and IL1B, IL6 and IL8 mRNA expression 
by qPCR (D – F; Beef heifers, n = 4; dairy cows, n = 4). Endometrial EVOCs collected from the 
caruncular (Closed bars, n = 4) and intercaruncular (Open bars, n = 4) areas of early luteal beef heifer 
endometrium (contralateral horn) were challenged with control medium or medium containing 1 
µg/ml LPS or 1 x 103 CFU/ml E. coli for 24 h. Supernatants were collected and analysed for IL-1β, IL-6 
and IL-8 by ELISA (G – I). Endometrial EVOCs collected from the intercaruncular areas of the 
ipsilateral (Open bars, n = 13) and contralateral (Closed bars, n = 13) horns of early luteal beef heifer 
endometrium were challenged with control medium or medium containing 1 µg/ml LPS for 24 h. 
Supernatants were collected and analysed for IL-1β, IL-6 and IL-8 by ELISA (J – L).Data are presented 
as mean (SEM), protein data as histograms; qPCR data as dot plots with the horizontal bar 
representing the mean and vertical bars SEM. Data were analysed by GLM multivariate ANOVA and 
Dunnett’s pairwise multiple comparison t-test, values differ between groups: *P < 0.05.  
 
Figure 2  
Ex vivo organ culture responses are not affected by the stage of oestrous cycle. Endometrial EVOCs 
collected from the intercaruncular areas of  beef heifer endometrium (contralaterial horn)  at 
different stage of the oestrous cycle were challenged with control medium or medium containing 1 
µg/ml LPS or 1 x 103 CFU/ml E. coli for 6 (A – C: Follicular, open bars , n = 3; early luteal, grey bars, n 
= 10, mid luteal, closed bars, n = 20) or 24 h (D – F: Follicular, open bars, n = 6, early luteal, grey bars, 
n = 10, mid luteal, closed bars, n = 39). Supernatants were collected and analysed for IL-1β, IL-6 and 
IL-8 by ELISA. Data are presented as mean (SEM). Data were analysed by GLM multivariate ANOVA 
and Dunnett’s pairwise multiple comparison t-test, values differ between groups: *P < 0.05. 
 
Figure 3  
Gene expression within ex vivo organ cultures is not affected by the stage of oestrous cycle. 
Endometrial EVOCs collected from the intercaruncular areas of  beef heifer endometrium 
(contralateral horn) at different stages of the oestrous cycle were treated with control medium or 
medium containing 1 µg/ml LPS or 1 x 103 CFU/ml E. coli for 6 or 24 h. For 6 h treatment: Folliclar 
(), n = 3, early luteal (), n = 4, mid luteal(), n = 10. For 24 h treatment: Folliclar (), n = 3, early 
luteal (), n = 4, mid luteal (), n = 9. The EVOC tissues were collected and total RNA extracted for 
analysis of IL1B (A, B), IL6 (C, D), IL8 (E, F) and CCL5 (G, H) mRNA expression by qPCR. Data are 
presented in dot plots with the horizontal bar representing the mean and vertical bars SEM. Data 
were analysed by GLM mutlivariate ANOVA and Dunnett’s pairwise multiple comparison t-test, 
values differ between groups: *P < 0.05, and each dot represents an individual animal.. 
 
Figure 4  
Ovarian steroid receptor (ESR1 and PGR) expression in ex vivo organ cultures is regulated by 
progesterone and oestradiol but not by dexamethasone. Follicular (A, C) or luteal (B, D) phase 
endometrial EVOCs from the intercaruncular areas of beef heifer endometrium (contralateral horn) 
were treated for 48 h with control medium or medium containing 5 ng/ml progesterone, 3 pg/ml 
oestradiol or 5ng/ml dexamethasone. The EVOC tissues were collected and total RNA extracted for 
analysis of ESR1 (A, B) and PGR (C, D) mRNA expression by qPCR. For follicular EVOCs: Control, n = 6, 
oestradiol, n = 3, progesterone, n = 3, dexamethasone, n = ; for luteal EVOCs: control, n = 10, 
oestradiol, n = 4, progesterone, n = 4, dexamethasone, n = 6. Data are presented in dot plots with 
the horizontal bar representing the mean and vertical bars SEM. Data were analysed by ANOVA 
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using Dunett’s pairwise multiple comparison t-test, values differ from control: *P < 0.05, and each 
dot represents an individual animal. 
 
Figure 5  
Exogenous ovarian steroids do not regulate ex vivo organ culture responses to LPS or E. coli. 
Follicular (A, C, E) and luteal phase (B, D, F) endometrial EVOCs from the intercaruncluar areas of 
beef heifer endometrium (contralateral horn) were pre-treated for 24 h with control medium (Open 
bar) or medium containing 5 ng/ml progesterone (Chequered bar), 3 pg/ml oestradiol (Striped bar) 
or 5 ng/ml dexamethasone (Closed bar). After 24 h, the EVOCs were challenged with control medium 
or medium containing 1 µg/ml LPS or 1 x 103 CFU/ml E. coli for a further 24 h in the presence of the 
steroids. Supernatants were collected and analysed for IL-1β (A, B), IL-6 (C, D) and IL-8 (E, F) by ELISA. 
Data are presented as mean (SEM). Data were analysed by GLM multivariate ANOVA and Dunett’s 
pairwise multiple comparison t-test, values differ between groups: *P < 0.05. Number of animals (n) 
is indicated in the figure. 
 
Figure 6  
Ex vivo organ culture mRNA expression is regulated by dexamethsone, but not by the ovarian 
steroids. Follicular (A, C, E, G) or luteal phase (B, D, F, H) endometrial EVOCs from the intercaruncular 
areas of beef heifer endometrium (contralateral horn) were pre-treated for 24 h with control 
medium () or medium containing 5 ng/ml progesterone (), 3 pg/ml oestradiol () or 5 ng/ml 
dexamethasone (). The EVOCs were then challenged with control medium or medium containing 1 
µg/ml LPS or 1 x 103 CFU/ml E. coli for a further 24 h in the presence of the steroids. The EVOC 
tissues were collected and total RNA extracted for analysis of IL1B (A, B), IL6 (C, D), IL8 (E, F) and 
CCL5 (G, H) mRNA expression by qPCR. For follicular EVOCs: control, n = 6, oestradiol, n = 5, 
progesterone, n = 5, dexamethasone, n = 3. For Luteal EVOCs: control, n = 10, oestradiol, n = 6, 
progesterone. n = 6, dexamethasone, n = 4. Data are presented in dot plots with the horizontal bar 
representing the mean and vertical bars SEM. Data were analysed by GLM multivariate ANOVA and 
Dunett’s pairwise multiple comparison t-test, values differ between groups: *P < 0.05,  and each dot 
represents an individual animal.  
 
Figure 7  
Ovarian steroids do not regulate endometrial cell responses to LPS. Endometrial epithelial (A, D) and 
stromal (B, E) cells from the ipsilateral horn of early luteal phase beef herifer endometrium, and 
peripheral blood derived mononuclearcells (PBMCs; C, F) from beef heifers were pre-treated for 24 h 
with control medium (Open bar) or medium containing 5 ng/ml progesterone (Chequered bar), 3 
pg/ml oestradiol (Striped bar) or 5 ng/ml dexamethasone (Closed bar). After 24 h, the cells were 
challenged with control medium or medium containing 100 ng/ml LPS for a further 24 h in the 
presence of the steroids. Supernatants were collected and analysed for IL-6 (A – C) and IL-8 (D – F) by 
ELISA. Data are presented as mean (SEM). Data were analysed by GLM multivariate ANOVA and 
Dunett’s pairwise multiple comparison t-test, values differ from control: *P < 0.05. Number of 
animals, n = 4.  
 
Figure 8 
High concentrations of ovarian steroids do not regulate endometrial stromal cell responses to LPS. 
Endometrial stromal cells from the ipsilateral horn of early luteal phase beef heifer endometrium 
were pre-treated for 24 h with control medium or medium containing 1 to 30 pg/ml oestradiol (A, C, 
E), 1 to 30 ng/ml progesterone (B, D, F) or 5 ng/ml dexamethasone. After 24 h, the cells were 
challenged with control medium or medium containing 100 ng/ml LPS for a further 24 h in the 
presence of the steroids. Supernatants were collected and analysed for IL-6 (A, B) and IL-8 (C, D) by 
ELISA. Cell viability was determined by MTT assay (E, F). Data are presented as mean (SEM). Data 
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were analysed by ANOVA and Dunett’s pairwise multiple comparison t-test, values differ from LPS: 
*P < 0.05. Number of animals, n = 3. 
 
Figure 9  
Competitive inhibition of ovarian nuclear receptors within ex vivo organ cultures. Endometrial EVOCs 
were harvested from the intercaruncular areas of early luteal phase beef heifer endometrium 
(contralateral horn), and treated for 24 h with control medium or medium containing 3 pg/ml 
oestradiol and/or 100nM MPP (A, D, G), 5 ng/ml progesterone and/or 100 nM mifepristone (B, E, H) 
or 5 ng/ml dexamethasone and/or 100nM mifepristone (C, F, I). After 24 h EVOCs were challenged 
with control medium of medium containing 1 µg/ml LPS or 1 x 103 CFU/ml E. coli for a further 24 h in 
the presence of the steroids/antagonists. Supernatants were collected and analysed for IL-1β (A – C), 
IL-6 (D – F) and IL-8 (G – I) by ELISA. Data are presented as mean (SEM). Data were analysed by two-
way ANOVA and Dunett’s pairwise multiple comparison, values differ between groups: *P < 0.05. 
Number of animals (n) is indicated within the figure.  
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